Cargando…
CircIFNGR2 enhances proliferation and migration of CRC and induces cetuximab resistance by indirectly targeting KRAS via sponging to MiR-30b
Currently the clinical efficacy of colorectal cancer (CRC) which is the most common malignant tumors over the world has not reached an ideal level. Cetuximab, the monoclonal antibody targeting the extracellular domain of EGFR, has shown its great efficacy in the promotion of apoptosis and the inhibi...
Autores principales: | Zhang, Qi, Zheng, Yifeng, Liu, Jiajia, Tang, Xiaoxiao, Wang, Yuan, Li, Xianzheng, Li, Huibin, Zhou, Xiaoying, Tang, Shiru, Tang, Yitao, Wang, Xiaoyan, He, Han, Li, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839739/ https://www.ncbi.nlm.nih.gov/pubmed/36639711 http://dx.doi.org/10.1038/s41419-022-05536-8 |
Ejemplares similares
-
circIFNGR2 regulating ankylosing spondylitis-associated inflammation through macrophage polarization
por: Song, Minkai, et al.
Publicado: (2023) -
Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab
por: Zhang, Hangyu, et al.
Publicado: (2020) -
Negative correlation between acetyl-CoA acyltransferase 2 and cetuximab resistance in colorectal cancer: Correlation between ACAA2 and cetuximab resistance in CRC
por: Yuan, Yitao, et al.
Publicado: (2023) -
Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC
por: Tang, Xue-miao, et al.
Publicado: (2017) -
A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations
por: Chen, Dawei, et al.
Publicado: (2015)